| UHNF has received in the range of $10-25 million from [[pharmaceutical_companies:Gilead Sciences]] and [[pharmaceutical_companies:Roche]].((//2020/21 Report to Our Donors.// UHN Foundation. Retrieved May 6, 2022, from https://web.archive.org/web/20220507012703/https://uhnfoundation.ca/who-we-are/publications/2020-21-report-to-our-donors/)) Additional multi-million dollar donors include [[pharmaceutical_companies:AbbVie]], [[pharmaceutical_companies:Actelion]], [[pharmaceutical_companies:Amgen]], [[pharmaceutical_companies:Apotex]], [[pharmaceutical_companies:Astellas]], [[pharmaceutical_companies:AstraZeneca]], [[CIBC]], [[medical_technology_Companies:Medtronic]], [[pharmaceutical_companies:Novartis]], the [[RBC Foundation]], [[Scotiabank]], [[Barry Sherman]], [[Honey Sherman]], [[Sun Life Financial]] and [[TD Bank Group]]. | UHNF has received in the range of $10-25 million from [[pharmaceutical_companies:Gilead Sciences]] and [[pharmaceutical_companies:Roche]].((//2020/21 Report to Our Donors.// UHN Foundation. Retrieved May 6, 2022, from https://web.archive.org/web/20220507012703/https://uhnfoundation.ca/who-we-are/publications/2020-21-report-to-our-donors/)) Additional multi-million dollar donors include [[pharmaceutical_companies:Abbott]], [[pharmaceutical_companies:AbbVie]], [[pharmaceutical_companies:Actelion]], [[pharmaceutical_companies:Amgen]], [[pharmaceutical_companies:Apotex]], [[pharmaceutical_companies:Astellas]], [[pharmaceutical_companies:AstraZeneca]], [[pharmaceutical_companies:Axcan]], [[pharmaceutical_companies:Baxter]], [[pharmaceutical_companies:Bayer]], [[Bell]], [[pharmaceutical_companies:BlueRock Therapeutics]], [[BMO Financial Group]], [[pharmaceutical_companies:Boehringer Ingelheim]], [[Centre for Commercialization of Innovative Medicine]], [[CIBC]], [[pharmaceutical_companies:CymaBay Therapeutics]], [[Deloitte]], [[Ernst & Young]], [[pharmaceutical_companies:GlaxoSmithKline]], [[Imperial Oil]], [[pharmaceutical_companies:Janssen]], [[pharmaceutical_companies:Johnson & Johnson]], [[KPMG Foundation]], [[Loblaws]], [[pharmaceutical_companies:Lundbeck]], [[Manulife]], [[medical_technology_Companies:Medtronic]], [[pharmaceutical_companies:Merck]], [[pharmaceutical_companies:Novartis]], [[pharmaceutical_companies:Otsuka]], [[pharmaceutical_companies:Pfizer]], the [[RBC Foundation]], [[Research Manitoba]], [[Rogers Communications]], [[Scotiabank]], [[Barry Sherman]], [[Honey Sherman]], [[Sun Life Financial]], [[pharmaceutical_companies:Synthes]], [[TD Bank Group]], and the [[University of Toronto]]. |
